• Article

Evaluation of Risk Minimisation Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 mu g

Citation

Davis, K. H., Asiimwe, A., Zografos, L. J., McSorley, D. J., & Andrews, E. (2016). Evaluation of Risk Minimisation Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 mu g. Pharmacoepidemiology and Drug Safety, 25(S3), 309-310. DOI: 10.1002/pds.4070